-
41
Non-lethal sonodynamic therapy mitigates hypertensive renal fibrosis through the PI3K/AKT/mTORC1-autophagy pathway
Published 2025-02-01Subjects: Get full text
Article -
42
-
43
An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
Published 2020-01-01“…To evaluate effects of ursodeoxycholic acid (UDCA) on inflammation, steatosis and liver fibrosis and atherogenesis factors in patients with non-alcoholic fatty liver disease (NAFLD).Materials and methods. …”
Get full text
Article -
44
Yiqi Juanshen decoction alleviates renal interstitial fibrosis by targeting the LOXL2/PI3K/AKT pathway to suppress EMT and inflammation
Published 2025-02-01Subjects: Get full text
Article -
45
-
46
Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease
Published 2025-02-01Subjects: Get full text
Article -
47
The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis
Published 2023-10-01“…# Background Inhaled hypertonic saline (HS) is an effective mucolytic agent in patients with cystic fibrosis (CF). However, adverse events can impair the clinical utility of hypertonic saline (HS) in this patient population. …”
Get full text
Article -
48
Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production
Published 2025-01-01Subjects: Get full text
Article -
49
Ultrasound radiomics-based logistic regression model for fibrotic NASH
Published 2025-02-01Subjects: “…Liver fibrosis…”
Get full text
Article -
50
Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study
Published 2025-01-01“…According to RCS, CVAI, MASLD, and fibrosis, all had positive relationships. CVAI had AUROCs of 0.759 and 0.771 for diagnosing MASLD and fibrosis, respectively. …”
Get full text
Article -
51
-
52
Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis
Published 2025-02-01Subjects: Get full text
Article -
53
-
54
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
Published 2025-02-01Subjects: Get full text
Article -
55
Chronic hepatitis C course at elderly and therapeutic approach
Published 2011-02-01Subjects: Get full text
Article -
56
Association of liver biopsy pathology on outcome of patients undergoing heart transplantation
Published 2025-02-01Subjects: Get full text
Article -
57
Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
Published 2018-09-01Subjects: Get full text
Article -
58
-
59
Promoting ER stress in a plasmacytoid dendritic cell line drives fibroblast activation
Published 2025-02-01Subjects: Get full text
Article -
60
Cross-talk of renal cells through WNT signal transduction in the development of fibrotic kidneys
Published 2025-02-01Subjects: Get full text
Article